On (b)(6) 2024, the patient was treated for abdominal aortic aneurysm.After implanting several aortic devices to treat the aneurysm in the aorta, the physician also wanted to extend deep into the internal iliac to treat an aneurysm in that vessel.After implanting an iliac branch endoprosthesis, the physician then implanted a gore® viabahn® vbx balloon expandable endoprosthesis.While deploying the device, the last stent ring did not open fully.The physician used a secondary balloon to complete full expansion of the stent graft, also causing a small perforation of the vessel.The physician then coiled the hypogastric intentionally, and the issue was resolved.The patient tolerated the procedure.
|
A review of the manufacturing records indicated the device met pre-release specifications.This complaint was initiated based on information received from the field.Neither clinical images enabling direct assessment of product performance nor the product itself were returned for evaluation the available patient information did not add relevant information to further the device functionality investigation.Although the hypogastric was coiled / occluded intentionally, we are reporting the stent occlusion within the 30 days time frame.The gore® viabahn® vbx balloon expandable endoprosthesis instruction for use (ifu), section hazards and adverse events states, complications and adverse events can occur when using any endovascular device.These complications include, but are not limited to: thrombosis or occlusion.Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|